For: | Su JJ, Xu K, Wang PF, Zhang HY, Chen YL. Histological analysis of human pancreatic carcinoma following irreversible electroporation in a nude mouse model. World J Gastrointest Oncol 2018; 10(12): 476-486 [PMID: 30595801 DOI: 10.4251/wjgo.v10.i12.476] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v10/i12/476.htm |
Number | Citing Articles |
1 |
Peipei Yang, Xin Zhi, Yunxue Xu, Linxue Qian, Zhifei Dai. Nanomedicines enhance minimally invasive therapy of pancreatic cancer. Nano Today 2023; 51: 101891 doi: 10.1016/j.nantod.2023.101891
|
2 |
Luca Costantino, Stefania Ferrari, Matteo Santucci, Outi MH Salo-Ahen, Emanuele Carosati, Silvia Franchini, Angela Lauriola, Cecilia Pozzi, Matteo Trande, Gaia Gozzi, Puneet Saxena, Giuseppe Cannazza, Lorena Losi, Daniela Cardinale, Alberto Venturelli, Antonio Quotadamo, Pasquale Linciano, Lorenzo Tagliazucchi, Maria Gaetana Moschella, Remo Guerrini, Salvatore Pacifico, Rosaria Luciani, Filippo Genovese, Stefan Henrich, Silvia Alboni, Nuno Santarem, Anabela da Silva Cordeiro, Elisa Giovannetti, Godefridus J Peters, Paolo Pinton, Alessandro Rimessi, Gabriele Cruciani, Robert M Stroud, Rebecca C Wade, Stefano Mangani, Gaetano Marverti, Domenico D'Arca, Glauco Ponterini, Maria Paola Costi. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth. eLife 2022; 11 doi: 10.7554/eLife.73862
|
3 |
Stavros Spiliopoulos, Lazaros Reppas, Dimitrios Filippiadis, Antonella Delvecchio, Maria Conticchio, Riccardo Memeo, Riccardo Inchingolo. Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. World Journal of Gastroenterology 2023; 29(2): 223-231 doi: 10.3748/wjg.v29.i2.223
|
4 |
Andrea Coppola, Dario Grasso, Federico Fontana, Filippo Piacentino, Roberto Minici, Domenico Laganà, Anna Maria Ierardi, Gianpaolo Carrafiello, Fabio D’Angelo, Giulio Carcano, Massimo Venturini. Innovative Experimental Ultrasound and US-Related Techniques Using the Murine Model in Pancreatic Ductal Adenocarcinoma: A Systematic Review. Journal of Clinical Medicine 2023; 12(24): 7677 doi: 10.3390/jcm12247677
|
5 |
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee. Clinical Application of Repurposed Drugs. Progress in Molecular Biology and Translational Science 2024; 207: 123 doi: 10.1016/bs.pmbts.2024.03.032
|
6 |
Veronica M. Ringel-Scaia, Natalie Beitel-White, Melvin F. Lorenzo, Rebecca M. Brock, Kathleen E. Huie, Sheryl Coutermarsh-Ott, Kristin Eden, Dylan K. McDaniel, Scott S. Verbridge, John H. Rossmeisl, Kenneth J. Oestreich, Rafael V. Davalos, Irving C. Allen. High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity. eBioMedicine 2019; 44: 112 doi: 10.1016/j.ebiom.2019.05.036
|
7 |
Zainab L. Rai, Roger Feakins, Laura J. Pallett, Derek Manas, Brian R. Davidson. Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy. Journal of Clinical Medicine 2021; 10(8): 1609 doi: 10.3390/jcm10081609
|
8 |
Tiankuan Li, Wei Huang, Zhiyuan Wu, Yong Wang, Qingbing Wang, Ziyin Wang, Qin Liu, Jingjing Liu, Shenjie Wang, Xiaoyi Ding, Zhongmin Wang. Percutaneous Ablation of Hepatic Tumors at the Hepatocaval Confluence Using Irreversible Electroporation: A Preliminary Study. Current Oncology 2022; 29(6): 3950 doi: 10.3390/curroncol29060316
|